Vasodilator drugs in peripheral vascular disease.
D000818:Animals; D001157:Arterial Occlusive Diseases / Q000188:drug therapy; D003495:Cyclandelate / Q000627:therapeutic use; D004876:Ergot Alkaloids / Q000627:therapeutic use; D006801:Humans; D007511:Ischemia / Q000188:drug therapy; D007556:Isoxsuprine / Q000627:therapeutic use; D008750:Methyldopa / Q000627:therapeutic use; D009539:Nicotinic Acids / Q000627:therapeutic use; D009756:Nylidrin / Q000627:therapeutic use; D010208:Papaverine / Q000627:therapeutic use; D012039:Regional Blood Flow / Q000187:drug effects; D012110:Reserpine / Q000627:therapeutic use; D014043:Tolazoline / Q000627:therapeutic use; D014652:Vascular Diseases / Q000188:drug therapy*; D014665:Vasodilator Agents / Q000627:therapeutic use*
D004876:Ergot Alkaloids; D009539:Nicotinic Acids; D014665:Vasodilator Agents; D003495:Cyclandelate; D008750:Methyldopa; D009756:Nylidrin; D012110:Reserpine; D014043:Tolazoline; D010208:Papaverine; D007556:Isoxsuprine